Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening

Authors: Paula Tiittala, Karolina Tuomisto, Taneli Puumalainen, Outi Lyytikäinen, Jukka Ollgren, Olli Snellman, Otto Helve

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Infectious disease screening of migrants at increased risk is a feature of national infection prevention and control measures. Asylum seekers in Finland are offered screening of tuberculosis (TB), hepatitis B, human immunodeficiency virus infection (HIV) and syphilis based on individual risk assessment. We aimed to evaluate the public health response to a large influx of asylum seekers to Finland in 2015–2016 with respect to national guidelines on initial health services and infectious disease screening.

Methods

We used immigration and healthcare procurement data for all 38,134 asylum seekers to Finland during 2015–2016 to assess the implementation, timing and yields of infectious disease screening.

Results

The coverage of pulmonary TB screening was 71.6% [95% CI 71.1–72.0%] and that of hepatitis B, HIV or syphilis 60.6% [60.1–61.1%] among those eligible for screening. The estimated average delay from arrival to pulmonary TB screening was 74 days for adults and 43 days for children. Delay to hepatitis B, HIV and syphilis screening was 91 days for adults and 47 days for children. The seroprevalence of hepatitis B surface antigen positivity was 1.4% [95% CI 1.3–1.6%], HIV 0.3% [95% CI 0.1–0.4%] and Treponema pallidum specific antibodies 1.0% [95% CI 0.8–1.1%]. Data did not allow assessment of yields of pulmonary TB screening.

Conclusions

Up to one third  of asylum seekers were not reached by screening and screenings were delayed from target timeframes. Children, as a vulnerable population, were screened earlier than adults. To ensure higher screening coverage, infectious disease risks should be reassessed and screening completed at contacts to healthcare during the post-asylum phase of integration. The large influx of asylum seekers to Finland in 2015–2016 tested the country’s public health preparedness. After action reviews of the public health response to the large migrant influx such as screening implementation can be used for evidence-based improvement of public health preparedness and guidelines for initial health services and infectious disease screening.
Literature
3.
go back to reference Karki T, Napoli C, Riccardo F, Fabiani M, Dente MG, Carballo M, Noori T, Declich S. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening. Int J Environ Res Public Health. 2014;11(10):11004–14.CrossRef Karki T, Napoli C, Riccardo F, Fabiani M, Dente MG, Carballo M, Noori T, Declich S. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening. Int J Environ Res Public Health. 2014;11(10):11004–14.CrossRef
4.
go back to reference Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Tran R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Teixeira V, Ward B, Gratziou C, Migliori GB: Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe region survey of current practices. Eur Respir J 2016, 48(3):808–817.CrossRef Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Tran R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Teixeira V, Ward B, Gratziou C, Migliori GB: Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe region survey of current practices. Eur Respir J 2016, 48(3):808–817.CrossRef
5.
go back to reference Napoli C, Dente MG, Karki T, Riccardo F, Rossi P, Declich S, Network for the Control of Cross-Border Health Threats in the Mediterranean Basin and Black Sea. Screening for infectious diseases among newly arrived migrants: experiences and practices in Non-EU countries of the Mediterranean Basin and Black Sea. Int J Environ Res Public Health. 2015;12(12):15550–8.CrossRef Napoli C, Dente MG, Karki T, Riccardo F, Rossi P, Declich S, Network for the Control of Cross-Border Health Threats in the Mediterranean Basin and Black Sea. Screening for infectious diseases among newly arrived migrants: experiences and practices in Non-EU countries of the Mediterranean Basin and Black Sea. Int J Environ Res Public Health. 2015;12(12):15550–8.CrossRef
10.
go back to reference European Centre for Disease Prevention and Control (ECDC). Expert Opinion on the public health needs of irregular migrants, refugees or asylum seekers across the EU’s southern and south-eastern borders. 2015. European Centre for Disease Prevention and Control (ECDC). Expert Opinion on the public health needs of irregular migrants, refugees or asylum seekers across the EU’s southern and south-eastern borders. 2015.
15.
go back to reference Permanand G, Krasnik A, Kluge H, McKee M. Europe's migration challenges: mounting an effective health system response. Eur J Pub Health. 2016;26(1):3–4.CrossRef Permanand G, Krasnik A, Kluge H, McKee M. Europe's migration challenges: mounting an effective health system response. Eur J Pub Health. 2016;26(1):3–4.CrossRef
16.
go back to reference Jablonka A, Solbach P, Nothdorft S, Hampel A, Schmidt RE, Behrens GM. Low seroprevalence of syphilis and HIV in refugees and asylum seekers in Germany in 2015. Dtsch Med Wochenschr. 2016;141(14):e128–32.CrossRef Jablonka A, Solbach P, Nothdorft S, Hampel A, Schmidt RE, Behrens GM. Low seroprevalence of syphilis and HIV in refugees and asylum seekers in Germany in 2015. Dtsch Med Wochenschr. 2016;141(14):e128–32.CrossRef
17.
go back to reference Jablonka A, Solbach P, Wobse M, Manns MP, Schmidt RE, Wedemeyer H, Cornberg M, Behrens GMN, Hardtke S. Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015. Eur J Gastroenterol Hepatol. 2017;29(8):939–445.CrossRef Jablonka A, Solbach P, Wobse M, Manns MP, Schmidt RE, Wedemeyer H, Cornberg M, Behrens GMN, Hardtke S. Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015. Eur J Gastroenterol Hepatol. 2017;29(8):939–445.CrossRef
19.
go back to reference Marquardt L, Kramer A, Fischer F, Prufer-Kramer L. Health status and disease burden of unaccompanied asylum-seeking adolescents in Bielefeld, Germany: cross-sectional pilot study. Tropical Med Int Health. 2016;21(2):210–8.CrossRef Marquardt L, Kramer A, Fischer F, Prufer-Kramer L. Health status and disease burden of unaccompanied asylum-seeking adolescents in Bielefeld, Germany: cross-sectional pilot study. Tropical Med Int Health. 2016;21(2):210–8.CrossRef
20.
go back to reference Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minichini C, Di Caprio G, Starace M, Onorato L, Signoriello G, Macera M, Angelillo IF, Pasquale G, Sagnelli E: Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty 2017, 6(1):33. https://doi.org/10.1186/s40249-016-0228-4. Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minichini C, Di Caprio G, Starace M, Onorato L, Signoriello G, Macera M, Angelillo IF, Pasquale G, Sagnelli E: Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty 2017, 6(1):33. https://​doi.​org/​10.​1186/​s40249-016-0228-4.
21.
go back to reference Bennet R, Eriksson M. Tuberculosis infection and disease in the 2015 cohort of unaccompanied minors seeking asylum in northern Stockholm, Sweden. Infect Dis (Lond). 2017;49(7):501–6.CrossRef Bennet R, Eriksson M. Tuberculosis infection and disease in the 2015 cohort of unaccompanied minors seeking asylum in northern Stockholm, Sweden. Infect Dis (Lond). 2017;49(7):501–6.CrossRef
22.
go back to reference Bozorgmehr K, Wahedi K, Noest S, Szecsenyi J, Razum O. Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015. Eurosurveillance. 2017;22(40):16–00677. Bozorgmehr K, Wahedi K, Noest S, Szecsenyi J, Razum O. Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015. Eurosurveillance. 2017;22(40):16–00677.
23.
24.
go back to reference National Institute for Health and Welfare (THL). Countries with a high incidence of tuberculosis as well as diseases screened for among refugees and asylum seekers by country. 2015. National Institute for Health and Welfare (THL). Countries with a high incidence of tuberculosis as well as diseases screened for among refugees and asylum seekers by country. 2015.
25.
go back to reference Chernet A, Neumayr A, Hatz C, Kling K, Sydow V, Rentsch K, Utzinger J, Probst-Hensch N, Marti H, Nickel B, Labhardt ND. Spectrum of infectious diseases among newly arrived Eritrean refugees in Switzerland: a cross-sectional study. Int J Public Health. 2017. Chernet A, Neumayr A, Hatz C, Kling K, Sydow V, Rentsch K, Utzinger J, Probst-Hensch N, Marti H, Nickel B, Labhardt ND. Spectrum of infectious diseases among newly arrived Eritrean refugees in Switzerland: a cross-sectional study. Int J Public Health. 2017.
26.
go back to reference Kortas AZ, Polenz J, von Hayek J, Rudiger S, Rottbauer W, Storr U, Wibmer T: Screening for infectious diseases among asylum seekers newly arrived in Germany in 2015: a systematic single-centre analysis. Public Health 2017, 153:1–8.CrossRef Kortas AZ, Polenz J, von Hayek J, Rudiger S, Rottbauer W, Storr U, Wibmer T: Screening for infectious diseases among asylum seekers newly arrived in Germany in 2015: a systematic single-centre analysis. Public Health 2017, 153:1–8.CrossRef
28.
go back to reference Ackermann N, Marosevic D, Hormansdorfer S, Eberle U, Rieder G, Treis B, Berger A, Bischoff H, Bengs K, Konrad R, Hautmann W, Schonberger K, Belting A, Schlenk G, Margos G, Hoch M, Purner F, Fingerle V, Liebl B, Sing A. Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Euro Surveill. 2018;23(10). https://doi.org/10.2807/1560-7917.ES.2018.23.10.17%2D00176. Ackermann N, Marosevic D, Hormansdorfer S, Eberle U, Rieder G, Treis B, Berger A, Bischoff H, Bengs K, Konrad R, Hautmann W, Schonberger K, Belting A, Schlenk G, Margos G, Hoch M, Purner F, Fingerle V, Liebl B, Sing A. Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Euro Surveill. 2018;23(10). https://​doi.​org/​10.​2807/​1560-7917.​ES.​2018.​23.​10.​17%2D00176.
30.
go back to reference Eiset AH, Wejse C: Review of infectious diseases in refugees and asylum seekers-current status and going forward. Public Health Rev. 2017;38(22). Eiset AH, Wejse C: Review of infectious diseases in refugees and asylum seekers-current status and going forward. Public Health Rev. 2017;38(22).
32.
go back to reference Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, Duizer E, Boland G, de Melker H, van der Klis FRM, Hautvast JLA, Veldhuijzen IK: Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis a and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine 2018, 36(12):1664–1672.CrossRef Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, Duizer E, Boland G, de Melker H, van der Klis FRM, Hautvast JLA, Veldhuijzen IK: Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis a and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine 2018, 36(12):1664–1672.CrossRef
33.
go back to reference Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44611.CrossRef Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44611.CrossRef
35.
go back to reference Bozorgmehr K, Samuilova M, Petrova-Benedict R, Girardi E, Piselli P, Kentikelenis A. Infectious disease health services for refugees and asylum seekers during a time of crisis: a scoping study of six European Union countries. Health Policy. 2018. Bozorgmehr K, Samuilova M, Petrova-Benedict R, Girardi E, Piselli P, Kentikelenis A. Infectious disease health services for refugees and asylum seekers during a time of crisis: a scoping study of six European Union countries. Health Policy. 2018.
36.
go back to reference Kentikelenis A, Karanikolos M, Williams G, Mladovsky P, King L, Pharris A, Suk JE, Hatzakis A, McKee M, Noori T, Stuckler D. How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review. Eur J Pub Health. 2015;25(6):937–44.CrossRef Kentikelenis A, Karanikolos M, Williams G, Mladovsky P, King L, Pharris A, Suk JE, Hatzakis A, McKee M, Noori T, Stuckler D. How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review. Eur J Pub Health. 2015;25(6):937–44.CrossRef
37.
go back to reference Khan MS, Osei-Kofi A, Omar A, Kirkbride H, Kessel A, Abbara A, Heymann D, Zumla A, Dar O. Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis. Lancet Infect Dis. 2016;16(8):e173–7.CrossRef Khan MS, Osei-Kofi A, Omar A, Kirkbride H, Kessel A, Abbara A, Heymann D, Zumla A, Dar O. Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis. Lancet Infect Dis. 2016;16(8):e173–7.CrossRef
Metadata
Title
Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening
Authors
Paula Tiittala
Karolina Tuomisto
Taneli Puumalainen
Outi Lyytikäinen
Jukka Ollgren
Olli Snellman
Otto Helve
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-6038-9

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue